GlucoTrack
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlucoTrack and other ETFs, options, and stocks.About GCTK
GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid.
CEOPaul V. Goode
CEOPaul V. Goode
Employees11
Employees11
HeadquartersRutherford, New Jersey
HeadquartersRutherford, New Jersey
Founded2001
Founded2001
Employees11
Employees11
GCTK Key Statistics
Market cap4.30M
Market cap4.30M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume7.29M
Average volume7.29M
High today$0.157
High today$0.157
Low today$0.1271
Low today$0.1271
Open price$0.145
Open price$0.145
Volume2.08M
Volume2.08M
52 Week high$62.60
52 Week high$62.60
52 Week low$0.1271
52 Week low$0.1271
GCTK News
TipRanks 2d
GlucoTrack Reports Q1 2025 Financial Results and ProgressProtect Your Portfolio Against Market Uncertainty The latest announcement is out from GlucoTrack ( (GCTK) ). On May 14, 2025, Glucotrack reported its financia...
People also own
Based on the portfolios of people who own GCTK. This list is generated using Robinhood data, and it’s not a recommendation.